Re: Insights to Bacterial MS and other de-generative disease
Posted: Wed May 15, 2013 5:57 am
MacKintosh,you are missing the point.Look into that, the difference between different MS types is not just the rate of progression.
That is why I tried to get different papers here from professionals as our views are flawed. We are not trained neuros. We do not know much about the illness, only our own experience. That is not much. Can you substatiate your theory?
It just skipped my attention that it was posted not long ago here:
"Long-term antibiotic treatment with roxithromycin in patients with multiple sclerosis.
Woessner R, Grauer MT, Frese A, Bethke F, Ginger T, Hans A, Treib J.
Source
Dept. of Neurology, Westpfalz Medical Center, 67655, Kaiserslautern, Germany.
Abstract
BACKGROUND:
There are conflicting results concerning an association between Chlamydia pneumoniae and MS (multiple sclerosis). In the present study, we investigated a possible therapeutic option with antibiotics.
PATIENTS AND METHODS:
In our randomized, placebo-controlled double-blind study, 28 patients with the confirmed diagnosis of MS [61% relapsing-remitting MS (RR-MS), 32% secondary chronic-progressive MS (SP-MS) and 7% primary chronic progressive MS (PP-MS)] were treated over a time period of 12 months with three cycles of a 6-week oral antibiotic therapy with roxithromycin (300 mg per day) or placebo.
RESULTS:
No significant differences were observed in patients with RR-MS regarding the expanded disability status scale (EDSS) and the relapse rate when comparing treatment with roxithromycin and placebo.
CONCLUSION:
Our study shows that the patients with MS do not profit from a long-term antibiotic treatment with roxithromycin compared to placebo treatment. A causative connection between bacterial infections with C. pneumonia and MS therefore does seem very unlikely"
I know this study only involve roxytromicin, but at least they completed one. More than 6 years passed by since, but I have not seen anything like that from the other side. The only good thing that I can read out from this study that it is likely that a 12 month treatment is fairly safe.

It just skipped my attention that it was posted not long ago here:
"Long-term antibiotic treatment with roxithromycin in patients with multiple sclerosis.
Woessner R, Grauer MT, Frese A, Bethke F, Ginger T, Hans A, Treib J.
Source
Dept. of Neurology, Westpfalz Medical Center, 67655, Kaiserslautern, Germany.
Abstract
BACKGROUND:
There are conflicting results concerning an association between Chlamydia pneumoniae and MS (multiple sclerosis). In the present study, we investigated a possible therapeutic option with antibiotics.
PATIENTS AND METHODS:
In our randomized, placebo-controlled double-blind study, 28 patients with the confirmed diagnosis of MS [61% relapsing-remitting MS (RR-MS), 32% secondary chronic-progressive MS (SP-MS) and 7% primary chronic progressive MS (PP-MS)] were treated over a time period of 12 months with three cycles of a 6-week oral antibiotic therapy with roxithromycin (300 mg per day) or placebo.
RESULTS:
No significant differences were observed in patients with RR-MS regarding the expanded disability status scale (EDSS) and the relapse rate when comparing treatment with roxithromycin and placebo.
CONCLUSION:
Our study shows that the patients with MS do not profit from a long-term antibiotic treatment with roxithromycin compared to placebo treatment. A causative connection between bacterial infections with C. pneumonia and MS therefore does seem very unlikely"
I know this study only involve roxytromicin, but at least they completed one. More than 6 years passed by since, but I have not seen anything like that from the other side. The only good thing that I can read out from this study that it is likely that a 12 month treatment is fairly safe.